Tag Archives: Frank Comhaire

Boosting health recovery by food supplements: the case of ME/CFS v Post-Covid-19 syndrome 

Posted on 12/16/2021 by wames

Boosting health recovery by food supplements: the case of ME/CFS versus Post-Covid-19 Syndrome, by Frank Comhaire and Jan Pen in J Clin Pharmacol Ther. 2021;2(3):JCPT-02-1022   Research abstract:   Background and objectives: Other than the direct impact of cardiopulmonary sequelae, COVID-19 disease may cause … Continue reading →

Posted in News | Tagged , , , , , | Comments Off on Boosting health recovery by food supplements: the case of ME/CFS v Post-Covid-19 syndrome 

News & views in ME/CFS: the role of co-morbidity & novel treatments

Posted on 02/19/2020 by wames

News and views in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): The role of co-morbidity and novel treatments, by F Comhaire, JP Deslypere in Medical Hypotheses Vol 134, January 2020, 109444 [doi.org/10.1016/j.mehy.2019.109444]   Research abstract: Though affecting many thousands of patients, myalgic … Continue reading →

Posted in News | Tagged , , , , , , , , , | Comments Off on News & views in ME/CFS: the role of co-morbidity & novel treatments

Why do some ME/CFS patients benefit from treatment with sodium dichloroacetate, but others do not?

Posted on 10/02/2018 by wames

Why do some ME/CFS patients benefit from treatment with sodium dichloroacetate, but others do not?, by Frank Comhaire in Med Hypotheses 2018 Nov;120:65-67 [Epub 2018 Aug 25] Research abstract: Myalgic Encephalopathy/Chronic Fatigue Syndrome (ME/CFS) is an enigmatic disease the pathogenesis of which remains … Continue reading →

Posted in News | Tagged , , | Comments Off on Why do some ME/CFS patients benefit from treatment with sodium dichloroacetate, but others do not?

Treating patients suffering from (ME/CFS) with sodium dichloroacetate: a pilot trial

Posted on 03/14/2018 by wames

Research abstract: Treating patients suffering from myalgic encephalopathy/chronic fatigue syndrome ME/CFS) with sodium dichloroacetate: An open-label, proof-of-principle pilot trial, by Frank Comhaire in Medical hypotheses May 2018 Vol 114, Pp 45–48 Twenty-two consecutive patients suffering from refractory myalgic encephalitis/chronic fatigue syndrome … Continue reading →

Posted in News | Tagged , , , , | Comments Off on Treating patients suffering from (ME/CFS) with sodium dichloroacetate: a pilot trial